West Pharmaceutical Services

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$805,000
$804,300
$766,200
$698,200
Gross Profit
303,900
293,500
273,200
232,700
EBITDA
209,500
217,100
198,500
150,900
EBIT
162,500
174,100
157,100
110,900
Net Income
132,100
140,000
131,800
89,800
Net Change In Cash
805,000
804,300
766,200
698,200
Free Cash Flow
175,000
133,900
101,900
58,100
Cash
791,300
628,500
509,700
404,200
Basic Shares
72,700
72,700
72,800
73,000

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$3,073,700
$2,892,700
$2,951,100
$2,885,500
Gross Profit
1,103,300
1,002,200
1,132,700
1,138,900
EBITDA
723,600
743,800
844,100
808,100
EBIT
599,200
588,400
706,800
687,500
Net Income
493,700
492,700
593,400
585,900
Net Change In Cash
3,073,700
2,892,700
2,951,100
2,885,500
Cost of Revenue
142,200
Free Cash Flow
468,900
276,400
414,500
439,400
Cash
791,300
484,600
853,900
894,300
Basic Shares
72,700
73,700
75,300
75,800

Earnings Calls

QuarterEPS
2025-12-31
$2.04
2025-09-30
$1.96
2025-06-30
$1.84
2025-03-31
$1.45